MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-05-2026
TransMedics Group EV/EBITDA Ratio 2011-2026 | TMDX
Annual EV/EBITDA Ratio TransMedics Group
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -12.1 | -25.4 | -10.4 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -10.4 | -25.4 | -15.9 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
EDAP TMS S.A.
EDAP
|
-4.19 | $ 4.13 | -0.72 % | $ 155 M |  France |
 |
Apyx Medical Corporation
APYX
|
-28 | $ 3.67 | 3.09 % | $ 151 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | USA |
 |
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | USA |
 |
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
-8.6 | $ 7.52 | -2.97 % | $ 1.13 B | USA |
 |
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | USA |
 |
Helius Medical Technologies
HSDT
|
-0.0925 | $ 2.22 | 3.26 % | $ 1.35 M | USA |
 |
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-165 | $ 17.81 | 1.37 % | $ 418 M | USA |
 |
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | USA |
 |
LENSAR
LNSR
|
-1.48 | $ 5.64 | 7.84 % | $ 67.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-9.73 | $ 12.82 | 9.76 % | $ 363 M | USA |
 |
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | USA |
 |
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.61 | -0.08 % | $ 38 M | USA |
 |
LivaNova PLC
LIVN
|
20.1 | $ 71.86 | 1.32 % | $ 3.92 B |  Britain |
 |
Delcath Systems
DCTH
|
329 | $ 11.48 | 2.14 % | $ 411 M | USA |
 |
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Orthofix Medical
OFIX
|
31.1 | $ 11.65 | -3.48 % | $ 461 M |  Curacao |
 |
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M |  Canada |
 |
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.03 | - | $ 17.4 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-1.15 | - | - | $ 10.2 M | USA |
 |
Myomo
MYO
|
-3.47 | $ 0.83 | -5.05 % | $ 34.7 M | USA |
 |
Electromed
ELMD
|
26.4 | $ 26.93 | 0.26 % | $ 228 M | USA |
 |
Butterfly Network
BFLY
|
-3.9 | $ 4.16 | -2.0 % | $ 881 M | USA |
 |
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | USA |
 |
Profound Medical Corp.
PROF
|
-2.87 | $ 6.85 | -4.33 % | $ 207 M | Canada |
 |
Insulet Corporation
PODD
|
33.9 | $ 154.16 | -3.89 % | $ 10.8 B | USA |
 |
GBS
GBS
|
1.03 | - | -0.57 % | $ 7.12 M | USA |
 |
Sintx Technologies
SINT
|
0.974 | $ 2.35 | -2.08 % | $ 6.52 M | USA |
 |
Globus Medical
GMED
|
16.8 | $ 77.95 | -8.37 % | $ 10.5 B | USA |
 |
CONMED Corporation
CNMD
|
40.2 | $ 36.76 | -3.52 % | $ 1.14 B | USA |
 |
Stryker Corporation
SYK
|
30 | $ 285.47 | -2.98 % | $ 109 B | USA |
 |
Inspire Medical Systems
INSP
|
-152 | $ 44.26 | -2.87 % | $ 1.3 B | USA |
 |
Integer Holdings Corporation
ITGR
|
18.2 | $ 88.12 | 0.23 % | $ 3.06 B | USA |
 |
Invacare Corporation
IVC
|
1.89 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
34.7 | $ 79.96 | -3.44 % | $ 46.8 B | USA |
 |
Tandem Diabetes Care
TNDM
|
73.2 | $ 15.48 | -16.19 % | $ 1.05 B | USA |